Flutamide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Flutamide. Educational only — not medical advice.
Labeled uses
Eulexin™ capsules are indicated for use in combination with LHRH-agonists for the management of locally confined Stage B2 -C and Stage D2 metastatic carcinoma of the prostate.
Source: FDA labeling via NIH DailyMed (set 56b6ba36…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.